Target Price | KRW47,000.00 |
Price | KRW44,700.00 |
Potential |
5.15%
register free of charge
|
Number of Estimates | 3 |
3 Analysts have issued a price target SK Bioscience 2025 .
The average SK Bioscience target price is KRW47,000.00.
This is
5.15%
register free of charge
KRW60,000.00
34.23%
register free of charge
KRW40,000.00
10.51%
register free of charge
|
|
A rating was issued by 3 analysts: 0 Analysts recommend SK Bioscience to buy, 1 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the SK Bioscience stock has an average upside potential 2025 of
5.15%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Billion KRW | 369.51 | 232.49 |
19.10% | 37.08% | |
EBITDA Margin | -2.37% | -33.79% |
112.25% | 1,325.22% | |
Net Margin | 6.04% | -33.18% |
77.49% | 649.03% |
3 Analysts have issued a sales forecast SK Bioscience 2024 . The average SK Bioscience sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an SK Bioscience EBITDA forecast 2024. The average SK Bioscience EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast SK Bioscience 2024 . The average SK Bioscience net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share KRW | 290.65 | -1,004.00 |
81.79% | 445.43% | |
P/E | negative | |
EV/Sales | 10.20 |
1 Analysts have issued a SK Bioscience forecast for earnings per share. The average SK Bioscience <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the SK Bioscience stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.